GENTIAN DIAGNOSTICS ASA (GENT.OL) Fundamental Analysis & Valuation

OSL:GENT • NO0010748866

Current stock price

38 NOK
-0.6 (-1.55%)
Last:

This GENT.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. GENT.OL Profitability Analysis

1.1 Basic Checks

  • GENT had positive earnings in the past year.
  • In the past year GENT had a positive cash flow from operations.
  • In multiple years GENT reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: GENT reported negative operating cash flow in multiple years.
GENT.OL Yearly Net Income VS EBIT VS OCF VS FCFGENT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M

1.2 Ratios

  • GENT has a Return On Assets of 5.13%. This is in the better half of the industry: GENT outperforms 69.35% of its industry peers.
  • Looking at the Return On Equity, with a value of 6.47%, GENT is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • The Return On Invested Capital of GENT (8.73%) is better than 70.97% of its industry peers.
Industry RankSector Rank
ROA 5.13%
ROE 6.47%
ROIC 8.73%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GENT.OL Yearly ROA, ROE, ROICGENT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • GENT has a Profit Margin (7.51%) which is comparable to the rest of the industry.
  • Looking at the Operating Margin, with a value of 14.42%, GENT is in the better half of the industry, outperforming 69.35% of the companies in the same industry.
  • Looking at the Gross Margin, with a value of 55.64%, GENT is in line with its industry, outperforming 45.16% of the companies in the same industry.
  • In the last couple of years the Gross Margin of GENT has grown nicely.
Industry RankSector Rank
OM 14.42%
PM (TTM) 7.51%
GM 55.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.99%
GM growth 5Y2.77%
GENT.OL Yearly Profit, Operating, Gross MarginsGENT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. GENT.OL Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so GENT is still creating some value.
  • GENT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GENT.OL Yearly Shares OutstandingGENT.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
GENT.OL Yearly Total Debt VS Total AssetsGENT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • An Altman-Z score of 7.75 indicates that GENT is not in any danger for bankruptcy at the moment.
  • GENT has a better Altman-Z score (7.75) than 91.94% of its industry peers.
  • The Debt to FCF ratio of GENT is 0.61, which is an excellent value as it means it would take GENT, only 0.61 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 0.61, GENT belongs to the best of the industry, outperforming 91.94% of the companies in the same industry.
  • A Debt/Equity ratio of 0.09 indicates that GENT is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.09, GENT is doing good in the industry, outperforming 79.03% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.61
Altman-Z 7.75
ROIC/WACC1.02
WACC8.53%
GENT.OL Yearly LT Debt VS Equity VS FCFGENT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

  • GENT has a Current Ratio of 5.40. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
  • GENT has a better Current ratio (5.40) than 98.39% of its industry peers.
  • GENT has a Quick Ratio of 3.81. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
  • GENT's Quick ratio of 3.81 is amongst the best of the industry. GENT outperforms 93.55% of its industry peers.
Industry RankSector Rank
Current Ratio 5.4
Quick Ratio 3.81
GENT.OL Yearly Current Assets VS Current LiabilitesGENT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. GENT.OL Growth Analysis

3.1 Past

  • The earnings per share for GENT have decreased strongly by -70.75% in the last year.
  • GENT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.07%.
  • The Revenue has been growing by 22.75% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-70.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-89.41%
Revenue 1Y (TTM)16.07%
Revenue growth 3Y20.2%
Revenue growth 5Y22.75%
Sales Q2Q%9.35%

3.2 Future

  • The Earnings Per Share is expected to grow by 79.21% on average over the next years. This is a very strong growth
  • GENT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.00% yearly.
EPS Next Y204.65%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
EPS Next 5YN/A
Revenue Next Year19.34%
Revenue Next 2Y20.77%
Revenue Next 3Y19%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
GENT.OL Yearly Revenue VS EstimatesGENT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
GENT.OL Yearly EPS VS EstimatesGENT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 4

More info and screens

Find the best growth stocksShow best growing peers

5

4. GENT.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 44.71 indicates a quite expensive valuation of GENT.
  • The rest of the industry has a similar Price/Earnings ratio as GENT.
  • When comparing the Price/Earnings ratio of GENT to the average of the S&P500 Index (24.88), we can say GENT is valued expensively.
  • GENT is valuated correctly with a Price/Forward Earnings ratio of 14.22.
  • Based on the Price/Forward Earnings ratio, GENT is valued a bit cheaper than the industry average as 72.58% of the companies are valued more expensively.
  • GENT's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.19.
Industry RankSector Rank
PE 44.71
Fwd PE 14.22
GENT.OL Price Earnings VS Forward Price EarningsGENT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • GENT's Enterprise Value to EBITDA ratio is in line with the industry average.
  • GENT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. GENT is cheaper than 75.81% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.41
EV/EBITDA 14.72
GENT.OL Per share dataGENT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • GENT's earnings are expected to grow with 79.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y113.5%
EPS Next 3Y79.21%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. GENT.OL Dividend Analysis

5.1 Amount

  • GENT has a Yearly Dividend Yield of 1.55%. Purely for dividend investing, there may be better candidates out there.
  • In the last 3 months the price of GENT has falen by -31.65%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 1.21, GENT pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, GENT has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 1.55%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • GENT pays out 46.54% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP46.54%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
GENT.OL Yearly Income VS Free CF VS DividendGENT.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M
GENT.OL Dividend Payout.GENT.OL Dividend Payout, showing the Payout Ratio.GENT.OL Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

GENT.OL Fundamentals: All Metrics, Ratios and Statistics

GENTIAN DIAGNOSTICS ASA

OSL:GENT (3/27/2026, 7:00:00 PM)

38

-0.6 (-1.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners39.64%
Inst Owner ChangeN/A
Ins Owners2.68%
Ins Owner ChangeN/A
Market Cap585.96M
Revenue(TTM)176.50M
Net Income(TTM)13.26M
Analysts85.71
Price Target64.26 (69.11%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.55%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP46.54%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.97%
PT rev (3m)-5.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.5%
EPS NY rev (3m)-1.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-17.56%
Valuation
Industry RankSector Rank
PE 44.71
Fwd PE 14.22
P/S 3.32
P/FCF 18.41
P/OCF 13.76
P/B 2.86
P/tB 3.46
EV/EBITDA 14.72
EPS(TTM)0.85
EY2.24%
EPS(NY)2.67
Fwd EY7.03%
FCF(TTM)2.06
FCFY5.43%
OCF(TTM)2.76
OCFY7.27%
SpS11.45
BVpS13.29
TBVpS10.97
PEG (NY)0.22
PEG (5Y)N/A
Graham Number15.94
Profitability
Industry RankSector Rank
ROA 5.13%
ROE 6.47%
ROCE 11.34%
ROIC 8.73%
ROICexc 16.54%
ROICexgc 23.72%
OM 14.42%
PM (TTM) 7.51%
GM 55.64%
FCFM 18.03%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.99%
GM growth 5Y2.77%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 0.61
Debt/EBITDA 0.56
Cap/Depr 118.04%
Cap/Sales 6.1%
Interest Coverage 250
Cash Conversion 123.21%
Profit Quality 240.13%
Current Ratio 5.4
Quick Ratio 3.81
Altman-Z 7.75
F-Score6
WACC8.53%
ROIC/WACC1.02
Cap/Depr(3y)95.7%
Cap/Depr(5y)120.92%
Cap/Sales(3y)5.54%
Cap/Sales(5y)9.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-89.41%
EPS Next Y204.65%
EPS Next 2Y113.5%
EPS Next 3Y79.21%
EPS Next 5YN/A
Revenue 1Y (TTM)16.07%
Revenue growth 3Y20.2%
Revenue growth 5Y22.75%
Sales Q2Q%9.35%
Revenue Next Year19.34%
Revenue Next 2Y20.77%
Revenue Next 3Y19%
Revenue Next 5YN/A
EBIT growth 1Y61.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year128%
EBIT Next 3Y57.14%
EBIT Next 5YN/A
FCF growth 1Y1169.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y216.49%
OCF growth 3YN/A
OCF growth 5YN/A

GENTIAN DIAGNOSTICS ASA / GENT.OL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for GENTIAN DIAGNOSTICS ASA?

ChartMill assigns a fundamental rating of 6 / 10 to GENT.OL.


Can you provide the valuation status for GENTIAN DIAGNOSTICS ASA?

ChartMill assigns a valuation rating of 5 / 10 to GENTIAN DIAGNOSTICS ASA (GENT.OL). This can be considered as Fairly Valued.


Can you provide the profitability details for GENTIAN DIAGNOSTICS ASA?

GENTIAN DIAGNOSTICS ASA (GENT.OL) has a profitability rating of 4 / 10.


How financially healthy is GENTIAN DIAGNOSTICS ASA?

The financial health rating of GENTIAN DIAGNOSTICS ASA (GENT.OL) is 8 / 10.


What is the earnings growth outlook for GENTIAN DIAGNOSTICS ASA?

The Earnings per Share (EPS) of GENTIAN DIAGNOSTICS ASA (GENT.OL) is expected to grow by 204.65% in the next year.